To address it, we developed an innovative 3D model of the HER2-OE BC immune microenvironment, generated without animal-based matrices to avoid the confounding factors of exogenous signaling modulators, and in a dynamic culture system, which allows non-destructive sampling along extended culture times. The gene discussed is ERBB2; the disease is breast cancer.